Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

CompletedOBSERVATIONAL
Enrollment

2,089

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Hypertension
Interventions
DRUG

Telmisartan

Telmisartan 40mg or 80mg

DRUG

amlodipine

amlodipine 5mg or 10mg

Trial Locations (55)

Unknown

Boehringer Ingelheim Investigational Site 15, Busan

Boehringer Ingelheim Investigational Site 37, Busan

Boehringer Ingelheim Investigational Site 42, Busan

Boehringer Ingelheim Investigational Site 55, Busan

Boehringer Ingelheim Investigational Site 54, Chonbuk

Boehringer Ingelheim Investigational Site 18, Chonnam

Boehringer Ingelheim Investigational Site 48, Chungcheong

Boehringer Ingelheim Investigational Site 46, Daegu

Boehringer Ingelheim Investigational Site 31, Daejeon

Boehringer Ingelheim Investigational Site 39, Daejeon

Boehringer Ingelheim Investigational Site 40, Daejeon

Boehringer Ingelheim Investigational Site 41, Daejeon

Boehringer Ingelheim Investigational Site 45, Daejeon

Boehringer Ingelheim Investigational Site 14, Deagu

Boehringer Ingelheim Investigational Site 25, Deagu

Boehringer Ingelheim Investigational Site 26, Deagu

Boehringer Ingelheim Investigational Site 44, Gangwon

Boehringer Ingelheim Investigational Site 24, Gwangju

Boehringer Ingelheim Investigational Site 32, Gwangju

Boehringer Ingelheim Investigational Site 11, Gyeonggi-do

Boehringer Ingelheim Investigational Site 13, Gyeonggi-do

Boehringer Ingelheim Investigational Site 16, Gyeonggi-do

Boehringer Ingelheim Investigational Site 21, Gyeonggi-do

Boehringer Ingelheim Investigational Site 23, Gyeonggi-do

Boehringer Ingelheim Investigational Site 30, Gyeonggi-do

Boehringer Ingelheim Investigational Site 43, Gyeonggi-do

Boehringer Ingelheim Investigational Site 47, Gyeonggi-do

Boehringer Ingelheim Investigational Site 5, Gyeonggi-do

Boehringer Ingelheim Investigational Site 6, Gyeonggi-do

Boehringer Ingelheim Investigational Site 9, Gyeonggi-do

Boehringer Ingelheim Investigational Site 35, Gyeongnam

Boehringer Ingelheim Investigational Site 51, Jeju City

Boehringer Ingelheim Investigational Site 52, Jeju City

Boehringer Ingelheim Investigational Site 17, Jungnam

Boehringer Ingelheim Investigational Site 19, Jungnam

Boehringer Ingelheim Investigational Site 8, Jungnam

Boehringer Ingelheim Investigational Site 12, Seoul

Boehringer Ingelheim Investigational Site 1, Seoul

Boehringer Ingelheim Investigational Site 20, Seoul

Boehringer Ingelheim Investigational Site 22, Seoul

Boehringer Ingelheim Investigational Site 27, Seoul

Boehringer Ingelheim Investigational Site 28, Seoul

Boehringer Ingelheim Investigational Site 29, Seoul

Boehringer Ingelheim Investigational Site 2, Seoul

Boehringer Ingelheim Investigational Site 33, Seoul

Boehringer Ingelheim Investigational Site 34, Seoul

Boehringer Ingelheim Investigational Site 36, Seoul

Boehringer Ingelheim Investigational Site 38, Seoul

Boehringer Ingelheim Investigational Site 3, Seoul

Boehringer Ingelheim Investigational Site 49, Seoul

Boehringer Ingelheim Investigational Site 4, Seoul

Boehringer Ingelheim Investigational Site 50, Seoul

Boehringer Ingelheim Investigational Site 53, Seoul

Boehringer Ingelheim Investigational Site 7, Seoul

Boehringer Ingelheim Investigational Site 10, Ulan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY